Samaritan Pharmaceuticals, Inc. Announces Positive Data in Nonclinical (IND) In-Vitro Studies for Promising Alzheimer's Drug
LAS VEGAS, May 3, 2007 (PRIME NEWSWIRE) -- Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, is pleased to announce positive results were attained with its late-stage preclinical/nonclinical testing of Caprospinol (SP-233), with well recognized in-vitro models.